Short interest in Acumen Pharmaceuticals Inc (NASDAQ:ABOS) decreased during the last reporting period, falling from 1.56M to 1.27M. This put 2.83% of the company's publicly available shares short.

Short interest for Acumen Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Acumen Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 145.74K shares traded per day, it would take 8.7 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.